Moomoo AI 已提取核心信息
Pfizer Inc., the pharmaceutical giant, filed a Registration Statement on Form S-8 with the U.S. Securities and Exchange Commission (SEC) on February 23, 2024. This filing is in connection with the company's 2019 Stock Plan following the completion of its acquisition of Seagen Inc. on December 14, 2023. The registration statement pertains to the offering and sale of an additional 67,734,387 shares of Pfizer's common stock. These shares were added to the share reserves under the 2019 Stock Plan as a result of the acquisition. The documents required for the registration statement will be delivered to the participants of the plan and are available upon request. Pfizer's recent Annual Report and other relevant documents have been incorporated by reference into this registration statement, which will be updated with any subsequent filings with the SEC.
Pfizer Inc., the pharmaceutical giant, filed a Registration Statement on Form S-8 with the U.S. Securities and Exchange Commission (SEC) on February 23, 2024. This filing is in connection with the company's 2019 Stock Plan following the completion of its acquisition of Seagen Inc. on December 14, 2023. The registration statement pertains to the offering and sale of an additional 67,734,387 shares of Pfizer's common stock. These shares were added to the share reserves under the 2019 Stock Plan as a result of the acquisition. The documents required for the registration statement will be delivered to the participants of the plan and are available upon request. Pfizer's recent Annual Report and other relevant documents have been incorporated by reference into this registration statement, which will be updated with any subsequent filings with the SEC.
制药巨头辉瑞公司于2024年2月23日向美国证券交易委员会（SEC）提交了S-8表格的注册声明。该文件与该公司在2023年12月14日完成对西根公司的收购之后的2019年股票计划有关。注册声明涉及辉瑞再发行和出售67,734,387股普通股。由于此次收购，这些股票被添加到2019年股票计划下的股票储备中。注册声明所需的文件将交付给计划的参与者，并可应要求提供。辉瑞最近的年度报告和其他相关文件已以引用方式纳入本注册声明，该声明将在随后向美国证券交易委员会提交的任何文件中进行更新。
制药巨头辉瑞公司于2024年2月23日向美国证券交易委员会（SEC）提交了S-8表格的注册声明。该文件与该公司在2023年12月14日完成对西根公司的收购之后的2019年股票计划有关。注册声明涉及辉瑞再发行和出售67,734,387股普通股。由于此次收购，这些股票被添加到2019年股票计划下的股票储备中。注册声明所需的文件将交付给计划的参与者，并可应要求提供。辉瑞最近的年度报告和其他相关文件已以引用方式纳入本注册声明，该声明将在随后向美国证券交易委员会提交的任何文件中进行更新。
有用
没用